Literature DB >> 20868307

Occurrence of inflammatory bowel disease in four patients with juvenile idiopathic arthritis receiving etanercept or infliximab.

M Tarkiainen, P Tynjälä, P Vähäsalo, P Lahdenne.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20868307     DOI： 10.3109/03009742.2010.499878

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN： 0300-9742            Impact factor:   3.641


× No keyword cloud information.
  3 in total

1.  Increased incidence of inflammatory bowel disease on etanercept in juvenile idiopathic arthritis regardless of concomitant methotrexate use.

Authors:  Joeri W van Straalen; Roline M Krol; Gabriella Giancane; Violeta Panaviene; Laura Marinela Ailioaie; Pavla Doležalová; Marco Cattalini; Gordana Susic; Flavio R Sztajnbok; Despoina Maritsi; Tamas Constantin; Sujata Sawhney; Marite Rygg; Sheila Knupp Oliveira; Ellen Berit Nordal; Claudia Saad-Magalhães; Nadina Rubio-Perez; Marija Jelusic; Sytze de Roock; Nico M Wulffraat; Nicolino Ruperto; Joost F Swart
Journal:  Rheumatology (Oxford)       Date:  2022-05-05       Impact factor: 7.046

Review 2.  Juvenile spondyloarthropathies.

Authors:  R Hal Scofield; Andrea L Sestak
Journal:  Curr Rheumatol Rep       Date:  2012-10       Impact factor: 4.592

3.  Development of crohn's disease following treatment for juvenile idiopathic arthritis in a nigerian child: Case report and review of literature.

Authors:  Oluwafunmilayo Funke Adeniyi; Uyi Ima-Edomwonyi; A Emuobor Odeghe; I Vincent Onyekwelu
Journal:  Ann Afr Med       Date:  2019 Oct-Dec
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.